EMAIL THIS PAGE TO A FRIEND

Molecular Cancer Therapeutics

Preclinical characterization of RSM-932A, a novel anticancer drug targeting the human choline kinase alpha, an enzyme involved in increased lipid metabolism of cancer cells.


PMID 25487918

Abstract

We're sorry this abstract is currently not available.